Xtant Medical Holdings, Inc. (XTNT)Healthcare | Medical Devices | Belgrade, United States | NYSE American
0.38 USD
+0.05
(16.364%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.37 -0.01 (-0.014%) ⇩ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:37 a.m. EDT
The immediate outlook is severely clouded by a sharp, recent price collapse. After trading near $0.45 earlier in the session, the stock plunged to $0.31 before stabilizing around $0.33, reflecting a significant loss of momentum and technical structure. This weakness is compounded by a massive 35% contraction in revenue and negative operating margins, suggesting the core business is struggling to generate profitability despite modest cash flow. While the balance sheet remains intact with a healthy current ratio and manageable debt relative to equity, the company is burning through value with no dividend to offset the drag. The market consensus is surprisingly optimistic, citing a 'strong buy' rating and a target price nearly four times the current level, yet this optimism appears disconnected from the reality of shrinking sales and a stock that has lost 96% of its value over the last decade. Without a clear turnaround in revenue growth or a resolution to the profitability issues, the investment case remains fragile. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.099310 |
| AutoARIMA | 0.102806 |
| AutoETS | 0.102806 |
| MSTL | 0.103129 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 2.53 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.178 |
| Excess Kurtosis | -1.19 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 65.006 |
| Revenue per Share | 0.782 |
| Market Cap | 53,870,580 |
| Forward P/E | -9.60 |
| Beta | -0.14 |
| Profit Margins | -10.17% |
| Website | https://xtantmedical.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.39682537 |
| Address1 | 664 Cruiser Lane |
| All Time High | 1,080.0 |
| All Time Low | 0.27 |
| Ask | 0.371 |
| Ask Size | 100 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 8,527,140 |
| Average Daily Volume3 Month | 1,450,336 |
| Average Volume | 1,450,336 |
| Average Volume10Days | 8,527,140 |
| Beta | -0.14 |
| Bid | 0.4075 |
| Bid Size | 400 |
| Book Value | 0.285 |
| City | Belgrade |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.384 |
| Current Ratio | 2.162 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.4861 |
| Day Low | 0.3397 |
| Debt To Equity | 65.006 |
| Display Name | Xtant Medical |
| Dividend Date | 1,518,566,400 |
| Earnings Call Timestamp End | 1,786,451,400 |
| Earnings Call Timestamp Start | 1,786,451,400 |
| Earnings Timestamp | 1,786,451,400 |
| Earnings Timestamp End | 1,794,313,800 |
| Earnings Timestamp Start | 1,794,313,800 |
| Ebitda | -1,473,000 |
| Ebitda Margins | -0.01345 |
| Enterprise To Ebitda | -47.531 |
| Enterprise To Revenue | 0.639 |
| Enterprise Value | 70,012,576 |
| Eps Forward | -0.04 |
| Eps Trailing Twelve Months | -0.09 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.4018 |
| Fifty Day Average Change | -0.017800003 |
| Fifty Day Average Change Percent | -0.044300653 |
| Fifty Two Week Change Percent | -39.682537 |
| Fifty Two Week High | 0.95 |
| Fifty Two Week High Change | -0.566 |
| Fifty Two Week High Change Percent | -0.5957895 |
| Fifty Two Week Low | 0.27 |
| Fifty Two Week Low Change | 0.11399999 |
| Fifty Two Week Low Change Percent | 0.42222217 |
| Fifty Two Week Range | 0.27 - 0.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,277,991,000,000 |
| Float Shares | 54,177,807 |
| Forward Eps | -0.04 |
| Forward P E | -9.6 |
| Free Cashflow | 10,128,750 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 151 |
| Fullday Change | 0.054 |
| Fullday Change Percent | 16.3636 |
| Fullday Price | 0.37 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.59389 |
| Gross Profits | 65,047,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15648 |
| Held Percent Institutions | 0.56943 |
| Implied Shares Outstanding | 140,287,960 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,518,566,400 |
| Last Split Factor | 1:12 |
| Long Business Summary | Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana. |
| Long Name | Xtant Medical Holdings, Inc. |
| Market | us_market |
| Market Cap | 53,870,580 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_11129226 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -11,137,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 46,295,026 |
| Number Of Analyst Opinions | 2 |
| Open | 0.3452 |
| Operating Cashflow | 570,000 |
| Operating Margins | -0.18101999 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.74 |
| Phone | 406 388 0480 |
| Post Market Change | -0.013999999 |
| Post Market Change Percent | -3.645833 |
| Post Market Price | 0.37 |
| Post Market Time | 1,787,961,586 |
| Previous Close | 0.33 |
| Price Hint | 4 |
| Price To Book | 1.3473685 |
| Price To Sales Trailing12 Months | 0.4918475 |
| Profit Margins | -0.10168 |
| Quick Ratio | 0.977 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.054 |
| Regular Market Change Percent | 16.3636 |
| Regular Market Day High | 0.4861 |
| Regular Market Day Low | 0.3397 |
| Regular Market Day Range | 0.3397 - 0.4861 |
| Regular Market Open | 0.3452 |
| Regular Market Previous Close | 0.33 |
| Regular Market Price | 0.384 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 76,660,467 |
| Return On Assets | -0.0375 |
| Return On Equity | -0.25164 |
| Revenue Growth | -0.35 |
| Revenue Per Share | 0.782 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 140,287,960 |
| Shares Percent Shares Out | 0.0007 |
| Shares Short | 103,406 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 70,049 |
| Short Name | Xtant Medical Holdings, Inc. |
| Short Percent Of Float | 0.0018000001 |
| Short Ratio | 0.67 |
| Source Interval | 15 |
| State | MT |
| Symbol | XTNT |
| Target High Price | 1.5 |
| Target Low Price | 0.6 |
| Target Mean Price | 1.05 |
| Target Median Price | 1.05 |
| Total Cash | 9,870,000 |
| Total Cash Per Share | 0.07 |
| Total Debt | 26,012,000 |
| Total Revenue | 109,527,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.09 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.54155 |
| Two Hundred Day Average Change | -0.15754998 |
| Two Hundred Day Average Change Percent | -0.29092416 |
| Type Disp | Equity |
| Volume | 76,660,467 |
| Website | https://xtantmedical.com |
| Zip | 59,714 |